Uses of Citiark-500
A neurological supportive preparation used adjunctively after stroke and head injury, and in cognitive impairment of vascular origin.
This is an adjunctive category rather than a definitive treatment, and the evidence base is more mixed than for the drugs used to treat the underlying event. It is nonetheless widely prescribed in Indian neurology and neurosurgery practice, and hospitals stock it accordingly.
- Adjunctive therapy in acute ischaemic stroke and during recovery
- Traumatic brain injury, as directed
- Cognitive impairment of vascular origin
Indication categories, not an exhaustive list, and not a recommendation for any individual patient.
Quality-driven manufacturing behind Citiark-500
Why Monark Criticare versus a typical supplier?
Every row is a term stated elsewhere on this site and held to in writing. Nothing here is a claim about a certificate we have not seen.
Start your critical care business with Citiark-500 — take the district before it is allocated
Send the districts you cover and the segments you already sell into. You get the rate list, the pack sizes and a straight answer on availability, usually inside one working day.
Get franchise quoteGet franchise quote for Citiark-500
Interested in Citicoline 500 MG 2ML for your pharma franchise business? Fill the form and we come back with the rate list, the pack sizes and district availability.
- ✓Exclusive district rights, recorded in the agreement
- ✓Net rates, pack sizes and MRP issued before you commit
- ✓No minimum on the first two order cycles
- ✓Batch documentation and certificate of analysis with every consignment
Send enquiry
Fill in your details and we will contact you shortly.
